Cooper Companies Inc.
COO | NASDAQ
$59.53
-$0.81 (-1.34%)
At close: Oct 30, 2026, 3:59 PM ET
$60.00
+$0.47 (+0.79%)
Pre-market:
Nov 2, 2026, 9:20 AM ET
Company Profile
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Key Executives
| Name | Position |
|---|---|
| Albert G. White | President, Chief Executive Officer & Non-Independent Director |
| Brian G. Andrews | Executive VP, CFO & Principal Accounting Officer |
| Daniel G. McBride | Executive VP, COO General Counsel & Secretary |
| Gerard H. Warner | President of CooperVision, Inc. |
| Holly R. Sheffield | President of CooperSurgical, Inc. |
| Kim Duncan | Vice President of Investor Relations & Risk Management |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 17, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
| Sep 09, 2026 | 10-Q | Quarterly Report |
| Sep 09, 2026 | 8-K | Current Report |
| Jul 06, 2026 | 4 | Filing |
| Jul 06, 2026 | 3 | Filing |
| Jun 05, 2026 | 10-Q | Quarterly Report |
| Jun 04, 2026 | 8-K | Current Report |
Cooper Companies Inc.
| Country | United States |
| IPO Date | Jan 21, 1983 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 15,000 |
| CEO | Albert G. White |
Contact Details
6101 Bollinger Canyon Road San Ramon,
California 94583 United States
Stock Details
| Ticker Symbol | COO |
| Exchange | NASDAQ |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| CIK Code | 0000711404 |
| CUSIP Number | 216648501 |
| ISIN Number | US2166485019 |
| SIC Code | 3851 |
Recent News
- 2 days ago / prnewswire.comThe Cooper Companies (NASDAQ: COO) Scrutinized Over U.S. Channel Inventory Reductions Driving Stock Sharply Lower
- 5 days ago / globenewswire.comCooperCompanies Announces Leadership Transition and Board Refreshment
- 24 days ago / zacks.comWhy Is The Cooper Companies (COO) Up 0.2% Since Last Earnings Report?
- 26 days ago / fool.comCooper Companies Director Kurzius Buys 10,000 Shares for $539,100. What Does This Insider See in Shares?
- 27 days ago / fool.comCooper Companies Director Rosebrough Buys 10,000 Shares for $542,000. What Does His Move Say About This Eye Care Stock?
- 1 month ago / fool.comCooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?
- 1 month ago / globenewswire.comThe Cooper Companies (NASDAQ: COO) Scrutinized Over U.S. Channel Inventory Reductions Driving Stock Sharply Lower -- HBSS
- 1 month ago / fool.comPlanet Fitness COO Dumps 23% of His Direct Equity Stake After the Stock Crashed
- 1 month ago / fool.comAST SpaceMobile COO Dumps 12,000 Shares for $707,000 Amid a 47% One-Year Return
- 1 month ago / fool.comBloom Energy COO Chitoori Satish Sells Shares for $775,072
Add to Watchlist
Select watchlists to add or remove COO